Business Description
Baotou Dongbao Bio-Tech Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100001583
Compare
Compare
Traded in other countries / regions
300239.China IPO Date
2011-07-06Description
Baotou Dongbao Bio-Tech Co Ltd operates in pharmaceutical manufacturing industry. The products of the company include collage, photosensitive gelatin, medicinal gelatin, edible gelatin, and calcium hydrogen phosphate.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.6 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | 3.38 | |||||
| Interest Coverage | 33.85 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.25 | |||||
| Beneish M-Score | -3.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.8 | |||||
| 3-Year EBITDA Growth Rate | 38.6 | |||||
| 3-Year EPS without NRI Growth Rate | 106 | |||||
| 3-Year Book Growth Rate | 13.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.69 | |||||
| 9-Day RSI | 45.64 | |||||
| 14-Day RSI | 45.24 | |||||
| 6-1 Month Momentum % | -16.78 | |||||
| 12-1 Month Momentum % | -18.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.82 | |||||
| Quick Ratio | 3.78 | |||||
| Cash Ratio | 2.68 | |||||
| Days Inventory | 147.91 | |||||
| Days Sales Outstanding | 64 | |||||
| Days Payable | 75.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.53 | |||||
| Dividend Payout Ratio | 0.14 | |||||
| 3-Year Dividend Growth Rate | -4.7 | |||||
| Forward Dividend Yield % | 0.53 | |||||
| 5-Year Yield-on-Cost % | 0.54 | |||||
| 3-Year Average Share Buyback Ratio | -4.4 | |||||
| Shareholder Yield % | -7.77 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.32 | |||||
| Operating Margin % | 14.78 | |||||
| Net Margin % | 12.01 | |||||
| FCF Margin % | 6.95 | |||||
| ROE % | 7.06 | |||||
| ROA % | 4.5 | |||||
| ROIC % | 6.93 | |||||
| ROC (Joel Greenblatt) % | 10.56 | |||||
| ROCE % | 6.2 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 26.78 | |||||
| PE Ratio without NRI | 26.06 | |||||
| Shiller PE Ratio | 61.25 | |||||
| Price-to-Owner-Earnings | 163 | |||||
| PEG Ratio | 1.15 | |||||
| PS Ratio | 3.2 | |||||
| PB Ratio | 1.73 | |||||
| Price-to-Tangible-Book | 1.89 | |||||
| Price-to-Free-Cash-Flow | 42.9 | |||||
| Price-to-Operating-Cash-Flow | 14.14 | |||||
| EV-to-EBIT | 18.53 | |||||
| EV-to-EBITDA | 18.53 | |||||
| EV-to-Revenue | 2.72 | |||||
| EV-to-FCF | 38.88 | |||||
| Price-to-Projected-FCF | 3.1 | |||||
| Price-to-Median-PS-Value | 0.52 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.04 | |||||
| Price-to-Graham-Number | 1.48 | |||||
| Price-to-Net-Current-Asset-Value | 9.8 | |||||
| Earnings Yield (Greenblatt) % | 5.4 | |||||
| FCF Yield % | 2.28 | |||||
| Forward Rate of Return (Yacktman) % | 18.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baotou Dongbao Bio-Tech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 954.971 | ||
| EPS (TTM) (Â¥) | 0.183 | ||
| Beta | 0.68 | ||
| Volatility % | 35.98 | ||
| 14-Day RSI | 45.24 | ||
| 14-Day ATR (Â¥) | 0.179876 | ||
| 20-Day SMA (Â¥) | 5.0005 | ||
| 12-1 Month Momentum % | -18.93 | ||
| 52-Week Range (Â¥) | 3.63 - 6.8 | ||
| Shares Outstanding (Mil) | 593.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baotou Dongbao Bio-Tech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baotou Dongbao Bio-Tech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Baotou Dongbao Bio-Tech Co Ltd Frequently Asked Questions
What is Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239)'s stock price today?
The current price of SZSE:300239 is ¥4.90. The 52 week high of SZSE:300239 is ¥6.80 and 52 week low is ¥3.63.
When is next earnings date of Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239)?
The next earnings date of Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239) is .
Does Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239) pay dividends? If so, how much?
The Dividend Yield %  of Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239) is 0.53% (As of Today), Highest Dividend Payout Ratio of Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239) was 6.67. The lowest was 0.04. And the median was 0.59. The  Forward Dividend Yield % of Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239) is 0.53%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers